Literature DB >> 10484967

Adverse effects of donepezil in treating Alzheimer's disease associated with Down's syndrome.

J M Hemingway-Eltomey, A J Lerner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10484967     DOI： 10.1176/ajp.156.9.1470

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN： 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  7 in total

1.  Safety and efficacy of rivastigmine in adolescents with Down syndrome: a preliminary 20-week, open-label study.

Authors:  James H Heller; Gail A Spiridigliozzi; Blythe G Crissman; Jennifer A Sullivan; Rebecca L Eells; Jennifer S Li; P Murali Doraiswamy; K Ranga Krishnan; Priya S Kishnani
Journal:  J Child Adolesc Psychopharmacol       Date:  2006-12       Impact factor: 2.576

Review 2.  Pharmacokinetics of Chemotherapeutic Drugs in Pediatric Patients With Down Syndrome and Leukemia.

Authors:  Erik Hefti; Javier G Blanco
Journal:  J Pediatr Hematol Oncol       Date:  2016-05       Impact factor: 1.289

Review 3.  Pharmacotherapeutic Considerations for Individuals with Down Syndrome.

Authors:  Erik Hefti; Javier G Blanco
Journal:  Pharmacotherapy       Date:  2017-01-13       Impact factor: 4.705

Review 4.  Vulnerable elderly patients and overactive bladder syndrome.

Authors:  Stephen R Kraus; Tamara Bavendam; Tiffany Brake; Tomas L Griebling
Journal:  Drugs Aging       Date:  2010-09-01       Impact factor: 3.923

5.  Donepezil for the treatment of language deficits in adults with Down syndrome: a preliminary 24-week open trial.

Authors:  James H Heller; Gail A Spiridigliozzi; Jennifer A Sullivan; P Murali Doraiswamy; Ranga R Krishnan; Priya S Kishnani
Journal:  Am J Med Genet A       Date:  2003-01-15       Impact factor: 2.802

Review 6.  Rationale for the use of anticholinergic agents in overactive bladder with regard to central nervous system and cardiovascular system side effects.

Authors:  Bülent Cetinel; Bulent Onal
Journal:  Korean J Urol       Date:  2013-12-10

Review 7.  Donepezil for dementia in people with Down syndrome.

Authors:  Monica Mohan; Peter K Carpenter; Cathy Bennett
Journal:  Cochrane Database Syst Rev       Date:  2009-01-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.